Latest Manufacturing Scale News

Page 3 of 3

Mesoblast Secures A$260M to Propel Ryoncil® US Launch and Clinical Trials

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Ada Torres

14 Jan 2025

Browse the archive

Full archive

July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026 Dec 2025